| ACTIVASE CathFLO (Genentech) catheter clearance | KYNAPID (Astellas) acute atrial fibrillation |
| ACTHAR (Mallinckrodt) multiple sclerosis | LAMICTAL (GSK) bipolar disorder |
| ADVAIR (GSK) asthma | LOVENOX (Aventis) DVT, PE prophylaxis |
| ALLEGRA (Aventis) allergy | LUMASON (Bracco) echocardiography/sonography |
| APOKYN (Bertek) Parkinson’s disease | LYRICA (Pfizer) neuropathic pain |
| AVODART (GSK) benign prostatic hyperplasia | MYOZYME (Sanofi/Genzyme) Pompe disease |
| BOTOX (Allergan) cosmetic, migraine, spasticity, overactive bladder | MULTIHANCE (Bracco) MR contrast agent |
| CAMPRAL (Forest) alcohol dependence | NAMENDA (Forest) Alzheimer’s disease |
| CEREZYME (Sanofi/Genzyme) Gaucher disease | NEXAVAR (Bayer) renal cell carcinoma |
| CLIVIPREX (The Medicines Company) CABG | NOURIANZ (Kyowa Kirin) Parkinson’s disease |
| CRYSVITA (Kyowa Kirin) X-linked hypophosphatemia | OPTSION (GE Healthcare) echocardiography contrast |
| DIOVAN (Novartis) hypertension, congestive heart failure | POTELIGEO (Kyowa Kirin) mycosis fungoides |
| DOTAREM (Guerbet) MR contrast agent | PROHANCE (Bracco) MR contrast agent |
| ENDEAVOR (Medtronic) coronary/vascular stents | RESURGEX (Millennium) malnutrition |
| ENTEREG (Adolor/GSK) post-operative ileus | SAVAYSA (Daiichi Sankyo) atrial fibrillation |
| EXJADE (Novartis) sickle cell anemia | SURFAXIN (Discovery) neonatal respiratory distress |
| FABRAZYME (Sanofi/Genzyme) Fabry disease | SUTENT (Pfizer) gastrointestinal stromal tumors |
| FLOVENT (GSK) asthma | VAPRISOL (Astellas) hyponatremia and CHF |
| FRAGMIN (Eisai) DVT prophylaxis | VFEND (Pfizer) systemic fungal infections |
| KETEK (Aventis) upper respiratory tract infections | VUEWAY (Bracco) MR contrast agent |
| KOGENATE FS (Bayer) hemophilia A | YONSA (Churchill/Sun) prostate cancer |
| JUVIDERM (Allergan) cosmetic dermal filler | ZYVOX (Pfizer) VRE and MRSA infections |
Andy Galler Agency Strategist and Growth Officer 